Second cohort of Structured Operational Research Training of the European Tuberculosis Research Initiative: workshops 1 and 2 of 4
18–29 November 2019, Copenhagen, Denmark
In 2017, in accordance with the Tuberculosis Action Plan for the WHO European Region 2016–2020, WHO/Europe established the European Tuberculosis Research Initiative (ERI-TB) to support the scale-up of TB research in the Region. The primary aims of ERI-TB are to:
- define priority TB research areas and questions for countries in the Region;
- catalyse capacity-building on a country level; and
- facilitate and promote collaboration between research institutions and relevant stakeholders.
To achieve the second aim and catalyse uptake of the European Tuberculosis Research Agenda (made publicly available by WHO/Europe in 2019), ERI-TB implemented the first Structured Operational Research Training (SORT-TB) for 2018–2019.
The SORT-TB course is an innovative adaptation of previous results-oriented SORT-IT (Structured Operational Research and Training Initiative) courses, where participants are principal investigators of predetermined research questions.
In August 2019, ERI-TB launched the second SORT-TB course for all European Member States. It aims to:
- support priority research implementation in the Region;
- operate within the framework of WHO’s bilateral collaborative agreements with Member States; and
- support national counterparts to adapt country TB policies by translating research into action.
The course comprises 4 workshops, each of which focuses on a particular theme:
- Workshop 1: operational research and protocol development (18–23 November 2019);
- Workshop 2: efficient, quality-assured data capture and analysis (25–29 November 2019);
- Workshop 3: operational research and scientific paper writing (dates to be announced); and
- Workshop 4: research communication and transformation into practice (dates to be announced).
A group of 12 selected participants will take part in the second iteration of the SORT-TB course. For 5 applicants from 5 selected countries of the Region with a high burden of multidrug-resistant TB (Armenia, Azerbaijan, Belarus, Georgia and the Republic of Moldova), WHO/Europe will cover participation-related costs (travel, accommodation and per diem).
WHO/Europe’s work on TB in selected priority eastern European countries is funded by the United States Agency for International Development (USAID) through the regional platform to end TB in eastern Europe.
Contact and application
For any course-related inquires, please contact the WHO ERI-TB Secretariat at euroTBRI@who.int. Interested candidates must submit their applications using the instructions available through the link below.